Zepbound® cost without insurance
What brand-name Zepbound costs cash-pay in 2026 — the LillyDirect Self Pay Journey tiers, the 45-day refill rule, and how it compares with compounded tirzepatide.
Zepbound® cost without insurance
Zepbound is FDA-approved for chronic weight management. Cash-pay options have improved sharply via LillyDirect's Self Pay Journey Program.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| LillyDirect Self Pay — 2.5 mg starter | Brand vial | $299/mo | FDA-approved |
| LillyDirect Self Pay — 5 mg | Brand vial | $399/mo | FDA-approved |
| LillyDirect Self Pay — 7.5–15 mg (within 45-day refill) | Brand vial | $449/mo | FDA-approved |
| Standard self-pay if 45-day window missed | Brand vial | $599–$1,049/mo | FDA-approved |
| Retail KwikPen list (no discount) | Brand pen | ~$1,086/mo | FDA-approved |
| Compounded tirzepatide (for comparison) | Compounded | $186/mo (NexLife)* | Not FDA-approved |
LillyDirect self-pay uses single-dose vials and can't be billed to insurance. Missing the 45-day refill window reverts to standard tiers (7.5 mg $599 · 10 mg $699 · 12.5 mg $849 · 15 mg $1,049). See Zepbound vs compounded cost.
Questions
How much is Zepbound without insurance?
Via LillyDirect's Self Pay Journey Program: $299 (2.5 mg), $399 (5 mg), and $449 for 7.5–15 mg when refilled within 45 days; retail is ~$1,086/month. Zepbound is FDA-approved. See NexLife pricing
What happens if I miss the LillyDirect 45-day refill window?
Pricing reverts to standard self-pay tiers — about $599 (7.5 mg) up to $1,049 (15 mg) — until you re-enroll on your next order.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.